Prostate cancer
Post-Radical Prostatectomy Stereotactic Body Radiotherapy Shows Promise
Research published in JAMA Oncology suggests that post-radical prostatectomy (post-RP) stereotactic body radiotherapy (SBRT) is a well-tolerated treatment for prostate cancer, with patient-reported outcomes (PROs) comparable to those seen after postoperative conventionally fractionated radiotherapy (CFRT). The study, led by John Nikitas, M.D., of the University of California, Los Angeles,